LncRNA MALAT1 suppresses monocyte-endothelial cell interactions by targeting miR-30b-5p and enhancing ATG5-mediated

Xiaodong Gu1,2,3, Jingyuan Hou1,2,3, Jiawei Rao4

  • 1Meizhou Clinical Institute, Shantou University Medical College, Meizhou, 514000, China.

Heliyon
|April 11, 2024
PubMed
Abstract

Insights

Long non-coding RNA MALAT1 suppresses monocyte-endothelial cell interactions by targeting miR-30b-5p and enhancing autophagy. This suggests MALAT1 may protect against early atherosclerosis development.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • RNA Biology

Background:

  • Monocyte-endothelial cell (EC) interactions are pivotal in early atherosclerosis.
  • Molecular mechanisms regulating these interactions remain incompletely understood.
  • Investigating long non-coding RNAs (lncRNAs) offers potential insights.

Purpose of the Study:

  • To elucidate the role of lncRNA MALAT1 in monocyte-EC interactions.
  • To identify molecular pathways modulated by MALAT1 in this context.

Main Methods:

  • Assessed expression of MALAT1 and adhesion molecules in ApoE-/- mouse aortas and inflamed HUVECs.
  • Evaluated MALAT1's impact on monocyte-EC adhesion and autophagy.
  • Investigated MALAT1-microRNA interactions using luciferase and pull-down assays.

Main Results:

  • MALAT1 expression was reduced in atherosclerotic models.
  • MALAT1 overexpression inhibited adhesion molecules and monocyte adhesion to ECs.
  • MALAT1 acts as a sponge for miR-30b-5p, upregulating ATG5 and promoting endothelial autophagy.

Conclusions:

  • MALAT1 suppresses monocyte-EC interactions via miR-30b-5p and ATG5-mediated autophagy.
  • MALAT1 demonstrates a protective role in early atherosclerosis.